I joined the Health Services Research and Policy Department at LSHTM in 2017. My current research focuses on the cost-effectiveness of interventions to identify and diagnose individuals with Hepatitis B and C, and interventions to retain these individuals within care.

I also work with alongside the Clinical Trials Unit at LSHTM, helping to support health economic analyses, following the completion of trials, and helping to provide economic evidence for the value of performing research as part of a trial. This has included economic evaluations of tranexamic acid treatment for traumatic brain injury and gastrointestinal bleeding.

I completed by MSc in Public Health (Health Economics stream) at LSHTM. My MSc thesis was looking the cost-effectiveness of a spinal screening intervention for patients with metastatic prostate cancer. I have previously worked in Health Economic modelling for a private consultancy, working on cost-effectiveness and budget impact models, mostly for HTA submissions, in a variety of disease areas.